Dr Emmanuel Jaluchimike Iloputaife is a microbiologist whose work sits at the intersection of infectious disease research, phytomedicine, and molecular biotechnology. His academic path began with a BSc in Applied Microbiology and Brewing, followed by an MSc in Medical Microbiology, where he built a foundation in bacterial pathogenesis and antimicrobial resistance. Driven by curiosity and a steady ambition to solve real clinical problems, he went on to complete a PhD focused on Andrographis paniculata, a medicinal plant long recognised for its therapeutic potential. His research explored its phytochemical profile, antioxidant strength, and antibacterial activity against multi-drug-resistant organisms isolated from necrotising fasciitis. That work added new evidence to the growing interest in plant-based antimicrobials and their role in addressing the AMR crisis. Emmanuel later advanced his training in the United Kingdom, earning an MSc in Molecular Biotechnology from the University of Hertfordshire under the supervision of Dr Ralph Rapley (FRSB). There, he strengthened his skills in PCR, molecular diagnostics, and bioinformatics, and completed a project that deepened his interest in translational biotechnology.
Dr Iloputaife returned to Nigeria with a PCR machine he personally sourced, aiming to support capacity building in his home department at Enugu State University of Science and Technology (ESUT). He has taught at ESUT and the African Thinkers College of Education, shaping young scientists while continuing to publish across microbiology, phytochemistry, and medical biotechnology. Emmanuel has authored or co-authored about twenty peer-reviewed journal articles, with his ORCID record verifying his growing scholarly footprint. His work often appears in journals covering antimicrobial resistance, natural product research, and clinical microbiology. Beyond publications, he is committed to developing research ecosystems in Nigeria. He actively builds international collaborations, engages UK-based mentors, and contributes to discussions around technology transfer, genomics, and diagnostic innovation. His long-term vision is to strengthen local research infrastructure, expand molecular diagnostic capacity, and contribute to global efforts in infectious disease control. Emmanuel’s career reflects steady growth: from early teaching roles, to laboratory research, to international academic training, and now to a broader ambition of bridging science between Nigeria and the UK. Dr Iloputaife’s work continues to evolve, guided by a clear sense of purpose, using science to solve real problems and shaping the next phase of biotechnology-driven healthcare.
